BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21157335)

  • 1. Issues in renovascular disease and ischemic nephropathy: beyond ASTRAL.
    Textor SC
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):139-45. PubMed ID: 21157335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal artery stenosis: a common, treatable cause of renal failure?
    Textor SC; Wilcox CS
    Annu Rev Med; 2001; 52():421-42. PubMed ID: 11160787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic nephropathy: more than a simple renal artery narrowing.
    Khatami MR
    Iran J Kidney Dis; 2013 Mar; 7(2):82-100. PubMed ID: 23485531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic nephropathy in an elderly patient.
    Hoshide S; Kario K; Shimada K
    Geriatr Gerontol Int; 2008 Jun; 8(2):133-5. PubMed ID: 18713167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic nephropathy/azotemic renovascular disease.
    Textor SC; Wilcox CS
    Semin Nephrol; 2000 Sep; 20(5):489-502. PubMed ID: 11022902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherosclerotic nephropathy in renal artery stenosis--from randomized studies to individualized therapy].
    Oksa A; Dzúrik R; Demes M
    Vnitr Lek; 2003 Mar; 49(3):217-21. PubMed ID: 12728596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous revascularization for ischemic nephropathy: the past, present, and future.
    Textor SC; Misra S; Oderich GS
    Kidney Int; 2013 Jan; 83(1):28-40. PubMed ID: 23151953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic ischemic nephropathy. Epidemiology and clinical considerations.
    Novick AC
    Urol Clin North Am; 1994 May; 21(2):195-200. PubMed ID: 8178387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ischemic renal disease: revascularization or conservative treatment?].
    Rodríguez Jornet A; Ibeas J; Ribera L; Real J; Perendreu J; Falcó J; Vallespín J; Allegué N; Giménez Gaibar A; García García M
    Nefrologia; 2005; 25(3):258-68. PubMed ID: 16053007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endovascular management of atherosclerotic renovascular disease: early results following primary intervention.
    Corriere MA; Pearce JD; Edwards MS; Stafford JM; Hansen KJ
    J Vasc Surg; 2008 Sep; 48(3):580-7; discussion 587-8. PubMed ID: 18727962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revascularization in renal artery stenosis.
    Foy A; Ruggiero NJ; Filippone EJ
    Cardiol Rev; 2012; 20(4):189-93. PubMed ID: 22314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy?
    Greco BA; Breyer JA
    Semin Nephrol; 1996 Jan; 16(1):2-11. PubMed ID: 8720081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of atherosclerotic renovascular disease.
    Adamczak M; Więcek A
    Kidney Blood Press Res; 2011; 34(4):277-83. PubMed ID: 21691131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and management of renovascular hypertension and ischemic nephropathy.
    Yerram P; Karuparthi PR; Chaudhary K
    Minerva Urol Nefrol; 2012 Mar; 64(1):63-72. PubMed ID: 22402318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atherosclerotic nephropathy. Clinical manifestations of chronic arterial circulatory insufficiency of the kidneys].
    Krapf R
    Schweiz Med Wochenschr; 1990 Sep; 120(39):1415-20. PubMed ID: 2218463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal artery stenosis and chronic ischemic nephropathy: epidemiology and diagnosis.
    Kendrick J; Chonchol M
    Adv Chronic Kidney Dis; 2008 Oct; 15(4):355-62. PubMed ID: 18805381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renovascular hypertension: diagnostic and therapeutic challenges.
    Bosmans JL; De Broe ME
    JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS) study: rationale and study design.
    Rossi GP; Seccia TM; Miotto D; Zucchetta P; Cecchin D; Calò L; Puato M; Motta R; Caielli P; Vincenzi M; Ramondo G; Taddei S; Ferri C; Letizia C; Borghi C; Morganti A; Pessina AC;
    J Hum Hypertens; 2012 Aug; 26(8):507-16. PubMed ID: 21716318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic nephropathy: where are we now?
    Textor SC
    J Am Soc Nephrol; 2004 Aug; 15(8):1974-82. PubMed ID: 15284283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The long-term results on arterial pressure and kidney function after the percutaneous transluminal dilatation of renal artery stenosis].
    Rodríguez Pérez JC; Maynar Moliner M; Pérez Borges P; Plaza Toledano C; Reyes Pérez R; Pulido Duque JM; Palop Cubillo L; Rodríguez Pérez A
    Med Clin (Barc); 1997 Mar; 108(10):366-72. PubMed ID: 9139142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.